Kent Pharma

Kent Pharma is a prominent UK-based specialty pharmaceutical company that specializes in the development, manufacture, and distribution of generic medicines. The company is particularly recognized for its extensive portfolio of anti-infectives, including a leading position in the production of penicillin-based antibiotics. Beyond antibiotics, Kent Pharma provides a diverse range of products across therapeutic areas such as pain management, respiratory health, and cardiovascular medicine. Operating from its headquarters in Kent and utilizing specialized manufacturing facilities, the company supplies essential medicines to hospitals, pharmacies, and wholesalers globally. In 2019, the company was acquired by the private equity firm Duke Street, which has supported its growth as an independent entity in the specialty generics market.